Article Details
Retrieved on: 2022-07-27 08:39:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca's share price has outperformed its biotech stock peers in 2022 so far. Over the six-month timeframe, its London-listed stock is up 23% ...
Article found on: www.cmcmarkets.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here